Pelthos Therapeutics PTHS
NYSE PTHS
$20.13 +1.43 (+7.74%)
As of: Oct 22, 2026 · 9:42 AM EDT

Pelthos Therapeutics (PTHS) Interest Paid (2025 - 2026)

Updated

Analysis

Pelthos Therapeutics (PTHS) Interest Paid (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn -
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn -
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn -
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn -
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn 1.07 Bn
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn -
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn -
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn 1.25 Bn
10 Pelthos Therapeutics 71.25 Mn -17.14 Mn 11.99 Mn 797,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 797,000.00
Mar 31, 2026 691,000.00
Jun 30, 2025 19,000.00
API Access

Pelthos Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=PTHS&period=max&api_key=YOUR_API_KEY